^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    NGeneBio

    i
    Other names: NGeneBio | NGeneBio | NGeneBio Co., Ltd. | NGeneBio Co., Ltd | NGeneBio Co. Ltd. | NGeneBio Co. Ltd
    Related tests:
    Evidence

    News

    2ms
    NGeneBio expands NGS-breast cancer diagnostic to Thailand (Korea Biomedical Review)
    "NGeneBio said on Thursday that it launched its next-generation sequence (NGS)-based breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group....NGeneBio plans to provide its NGS-based precision diagnosis services to medium and large hospitals, government-affiliated medical institutions, health centers, and the general public through MP Group's newly opened laboratory. The service launched by the MP Group laboratory uses NGeneBio’s BRCAaccuTest PLUS test to identify the BRCA gene which is related to breast cancer and ovarian cancer."
    Launch non-US • Clinical
    |
    BRCAaccuTest PLUS
    2ms
    NGeneBio to commercialize liquid biopsy MRD test for AML by 2024 (Korea Biomedical Review)
    "NGeneBio said...that it signed a technology transfer contract with The Catholic University of Korea Industry-Academic Cooperation Foundation and Dow Biomedica to commercialize a product that can check the variation of minimal residual disease (MRD)."
    Commercial
    11ms
    NGeneBio receives CE-IVD mark for NGS-based cancer panel (Genomeweb)
    "South Korean diagnostics company NGeneBio said...that it has received CE-IVD marking for its next-generation sequencing-based comprehensive genomic profiling panel for cancer, OncoaccuPanel."
    European regulatory
    |
    OncoaccuPanel™